Tuberculosis in the elderly

Clinics in Geriatric Medicine

Volumn 19, Issue 1, 2003, Pages 121-138

  Zevallos, Mabel ^a   Justman, Jessica E ^a  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PLACEBO; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULIN; TUBERCULOSTATIC AGENT;

AGED; AMINOTRANSFERASE BLOOD LEVEL; AUTOPSY; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COMMUNITY; DRUG FATALITY; HEALTH PROGRAM; HEPATITIS; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION RISK; INSTITUTIONALIZATION; LIVER DISEASE; LIVER FAILURE; LIVER TOXICITY; NURSING HOME; PRACTICE GUIDELINE; REVIEW; SCREENING; SIDE EFFECT; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES;

AGED; ANTITUBERCULAR AGENTS; COMORBIDITY; HUMANS; INCIDENCE; ISONIAZID; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS, LYMPH NODE; TUBERCULOSIS, PLEURAL;

EID: 0037291537     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0690(02)00057-5     Document Type: Review

References (51)

1. Centers for Disease Control and Prevention, Division of Tuberculosis Elimination. National Surveillance System Highlights from 2000. Atlanta, GA: Centers for Disease Control and Prevention; 2001.
2. Centers for Disease Control and Prevention. Division of tuberculosis elimination. National Surveillance System Highlights from 1999. Atlanta, GA: Centers for Disease Control and Prevention; 2000.
3. US Census Bureau. Census 2000 Summary. Profile of General Demographic Characteristics. Washington DC: US Census Bureau; 2000.
4. Centers for Disease Control and Prevention. Prevention and Control of Tuberculosis in Facilities Providing Long-term Care to the Elderly: Recommendations of the Advisory Committee for Elimination of Tuberculosis: MMWR 39. Atlanta, GA: Centers for Disease Control and Prevention; 1990. p. 7-20.
5. Centers for Disease Control and Prevention. Core Curriculum on Tuberculosis. Atlanta, GA: US Department of Health and Human Services; 2001.
6. Centers for Disease Control and Prevention. Progress toward the elimination of tuberculosis - United States, 1998. MMWR 1999;48:732-6.
7. Stead WW, Lofgren JP, Warren E, et al. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985;312:1483-7.
8. Nisar M, Williams CS, Ashby D, et al. Tuberculin testing in residential homes for the elderly. Thorax 1993;48:1257-60.
9. Woo J, Chan HS, Hazlett CB, et al. Tuberculosis among elderly Chinese in residential homes: Tuberculin reactivity and estimated prevalence. Gerontology 1996;42:155-62.
10. Anonymous. 1997-1999 World Health Statistics Annual. Available at: http://www.who.int/whois/ (see Causes of Death).
11. American Thoracic Society/Centers for Disease Control. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-47.
12. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001;286:1740-7.
13. Streeton JA, Desem N, Jones SL. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis 1998;2:443-50.
14. American Thoracic Society/Centers for Disease Control. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-95.
15. Rooney JJ Jr, Crocco JA, Kramer S, et al. Further observations on tuberculin reactions in active tuberculosis. Am J Med 1976;60:517-22.
16. Crossley KB, Peterson PK. Infections in the elderly. Clin Infect Dis 1996;22:209-15.
17. Gelato MC. Aging and immune function: A possible role for growth hormone. Horm Res 1996;45:46-9.
18. Snider DEJ. Tuberculosis and gastrectomy. Chest 1985;87:414-5.
19. Thom PA, Brookes VS, Waterhouse JAH. Peptic ulcer, partial gastrectomy, and pulmonary tuberculosis. BMJ 1956;1:603-8.
20. Turett GS, Fazal BA, Justman JE, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis. Clin Infect Dis 1997;24:513-4.
21. Korzeniewska-Kosela M, Krysl J, Muller N, et al. Tuberculosis in young adults and the elderly. A prospective comparison study. Chest 1994;106:28-32.
22. Morris CD. Pulmonary tuberculosis in the elderly: A different disease? Thorax 1990;45:912-3.
23. Alvarez S, Shell C, Berk SL. Pulmonary tuberculosis in elderly men. Am J Med 1987;82:602-6.
24. Chan CH, Woo J, Or KK, et al. The effect of age on the presentation of patients with tuberculosis. Tuber Lung Dis 1995;76:290-4.
25. Liaw YS, Yang PC, Yu CJ, et al. Clinical spectrum of tuberculosis in older patients. J Am Geriatr Soc 1995;43:256-60.
26. Perez-Guzman C, Vargas MH, Torres-Cruz A, et al. Does aging modify pulmonary tuberculosis?: A meta-analytical review. Chest 1999;116:961-7.
27. Teale C, Goldman JM, Pearson SB. The association of age with the presentation and outcome of tuberculosis: A five-year survey. Age Ageing 1993;22:289-93.
28. Umeki S. Comparison of younger and elderly patients with pulmonary tuberculosis. Respiration 1989;55:75-83.
29. Sahn SA, Neff TA. Miliary tuberculosis. Am J Med 1974;56:494-505.
30. Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA 1979;241:264-8.
31. Jacobs LG, Justman J. Management of tuberculosis in the elderly. Resid Staff Physician 1994;40:11-7.
32. Christianson WI. Genitourinary tuberculosis: Review of 102 cases. Medicine 1974;53:377-90.
33. Rieder HL, Kelly GD, Bloch AB, et al. Tuberculosis diagnosed at death in the United States. Chest 1991;100:678-81.
34. Stead WW. Tuberculosis among elderly persons: An outbreak in a nursing home. Ann Intern Med 1981;94:604-10.
35. Griffith DE. Mycobacteria as pathogens of respiratory infection. Infect Dis Clin N Am 1998;12:593-611.
36. Anonymous. Rapid diagnostic tests for tuberculosis: What is the appropriate use? American Thoracic Society Workshop. Am J Respir Crit Care Med 1997;155:1804-18.
37. Kopanoff DE, Snider DE, Caras GJ. Isoniazid-related hepatitis: A U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978;117:991-1001.
38. Salpeter SR, Sanders GD, Salpeter EE, et al. Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: A risk-benefit and cost-effectiveness analysis. Ann Intern Med 1997;127:1051-61.
39. FitzGerald JM, Gafni A. A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test. Am Rev Respir Dis 1990;142:848-53.
40. Rose DN, Schechter CB, Fahs MC, et al. Tuberculosis prevention: Cost-effectiveness analysis of isoniazid chemoprophylaxis. Am J Prev Med 1988;4:102-9.
41. Rose DN, Schechter CB, Silver AL. The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors. JAMA 1986;256:2709-13.
42. Anonymous. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ 1982;60:555-64.
43. Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999;3:847-50.
44. Whalen CC, Johnson JL, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997;337:801-6.
45. Centers for Disease Control and Prevention. Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations - United States, 2001. MMWR 2001;50:733.
46. Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: A 7-year survey from a public health tuberculosis clinic. JAMA 1999;281:1014.
47. Rajagopalan S, Yoshikawa TT. Tuberculosis in long-term-care facilities. Infect Control Hosp Epidemiol 2000;21:611.
48. Bass JBJ, Farer LS, Hopewell PC, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med 1994;149:1359.
49. van den Brande P, van Steenbergen W, Vervoort G, et al. Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis. Am J Respir Crit Care Med 1995;152:1705.
50. Millard PS, Wilcosky TC, Reade-Christopher SJ, et al. Isoniazid-related fatal hepatitis. West J Med 1996;164:486.
51. Salpeter SR. Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis. West J Med 1993;159:560.